Curi RMB Capital
SAGE icon

Curi RMB Capital’s Sage Therapeutics SAGE Stock Holding History

Curi RMB Capital’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,289
Closed -$882K – 727
2019
Q3 		$882K Hold
6,289
– – 0.02% 403
2019
Q2 		$1.15M Buy
6,289
+6
+0.1% +$1.02K 0.03% 391
2019
Q1 		$999K Sell
6,283
-5,514
-47% -$799K 0.03% 449
2018
Q4 		$1.13M Sell
11,797
-496
-4% -$56.8K 0.03% 476
2018
Q3 		$1.74M Sell
12,293
-1,140
-8% -$176K 0.04% 413
2018
Q2 		$2.1M Sell
13,433
-6,555
-33% -$1.03M 0.05% 369
2018
Q1 		$3.22M Sell
19,988
-6,359
-24% -$1.08M 0.08% 309
2017
Q4 		$4.34M Sell
26,347
-14,903
-36% -$1.44M 0.11% 250
2017
Q3 		$2.57M Hold
41,250
– – 0.07% 336
2017
Q2 		$3.29M Buy
+41,250
New +$2.98M 0.09% 292

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Curi RMB Capital's SAGE Position: Q4 2019 in Review

Curi RMB Capital sold out of Sage Therapeutics (SAGE) in Q4 2019, closing a stake of 6,289 shares — an estimated $882K sold.

Curi RMB Capital first reported a position in SAGE in Q2 2017 and held it in 10 quarters. The position peaked at $4.34M in Q4 2017. 267 funds tracked by Wall St. Rank hold SAGE as of Q4 2019.

  • Curi RMB Capital reported no remaining Sage Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Curi RMB Capital sold 6,289 Sage Therapeutics shares in Q4 2019, an estimated $882K.
  • Curi RMB Capital first reported a position in Sage Therapeutics in Q2 2017 and held it in 10 quarters.
  • Curi RMB Capital's Sage Therapeutics position peaked at $4.34M in Q4 2017.
  • 267 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2019.

Based on Curi RMB Capital's 13F filing for Q4 2019, filed 13 Feb 2020.